The effect of oral ipriflavone on the rat mandible during growth.
Different types of ipriflavone (IF) have been reported to be effective when used as a remedy for bone loss due to osteoporosis. However, no information is available regarding the relationship between IF and jaw bone structure. The aim of this study was to examine the effect of IF on rat mandibles during the growth stage. Thirty-two 5-week-old Wistar male rats were divided into four groups. The control group was fed a standard diet, group A received a low calcium diet (calcium content 30 per cent of the standard diet) for 6 weeks, and the other two groups were fed a low calcium diet for 3 weeks and then a standard diet without IF (group B) or with IF (group C) for 3 weeks. In addition, distilled water was provided for all groups. The effects of IF on mandibular size and bone mineral content were investigated, using lateral cephalometric analysis and peripheral quantitative computed tomography (pQCT). For mandibular length, the control group showed a significantly higher value than groups A and B (P < 0.01, P < 0.05, respectively), while group C demonstrated a significantly higher value than group A (P < 0.01). In addition, the control group and group C showed significantly higher values for mandibular ramus height than group A (P < 0.01). However, bone mineral density in trabecular bone was significantly higher in the control group than in the other groups (P < 0.01) and bone mineral density in cortical bone was significantly higher in the control group than groups A, B and C (P < 0.01, P < 0.01, P < 0.05, respectively). Bone mineral density in both trabecular and cortical bone was significantly higher in group C than in groups A and B (P < 0.01, P < 0.05, respectively). These results indicate that complete recovery from calcium deficiency to the level of the control group may not be attainable, even though IF enhances calcium absorption to act on bone cells and promote bone construction. The importance of calcium intake in the early stages of development was confirmed. These findings also suggest an effect of IF on jaw bone structure.
Maki
Kenshi
K
Department of Pediatric Dentistry, Kyushu Dental College, Kitakyushu City, Japan. k-maki@hyu-dent.ac.jp
Nishida
Ikuko
I
Kimura
Mitsutaka
M
D000042:Absorption; D000284:Administration, Oral; D000818:Animals; D015519:Bone Density / Q000187:drug effects; D016723:Bone Remodeling / Q000187:drug effects*; D002118:Calcium / Q000172:deficiency / Q000493:pharmacokinetics; D002508:Cephalometry; D007529:Isoflavones / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008334:Mandible / Q000187:drug effects* / Q000254:growth & development / Q000378:metabolism; D010012:Osteogenesis / Q000187:drug effects; D011897:Random Allocation; D051381:Rats; D017208:Rats, Wistar; D014057:Tomography, X-Ray Computed / Q000379:methods
D007529:Isoflavones; C018986:ipriflavone; D002118:Calcium